PTEN rs121913059: Understanding PHTS Genetic Predispositions
The rs121913059 variant is a specific genetic alteration located within the PTEN gene. It is associated with PTEN hamartoma tumor syndrome (PHTS), a condition characterized by an increased lifetime risk for various benign and malignant tumors.
What each genotype means
Typical PTEN gene function
This genotype represents the typical, non-mutated state of the PTEN gene. Individuals with this profile do not carry the specific pathogenic variant associated with PTEN hamartoma tumor syndrome (PHTS) at this location.
This is the most common genotype found in the general population, as the pathogenic variant is extremely rare.
Increased cancer predisposition risk
This genotype indicates the presence of one copy of the pathogenic variant, which is associated with an autosomal dominant predisposition to PTEN hamartoma tumor syndrome (PHTS). Carriers may have an increased lifetime risk for developing hamartomatous polyps, as well as breast, thyroid, endometrial, and other cancers. Clinical management and cancer risk assessment should be discussed with a healthcare provider or genetic counselor.
This genotype is extremely rare, with the variant occurring at a global frequency of less than 0.00001 in population databases.
What is the rs121913059 Variant?
The rs121913059 variant is a specific change in the DNA sequence of the PTEN gene. In genetics, a variant like this represents a deviation from the most common sequence found in the general population. Because the PTEN gene is critical for regulating cell growth, changes in its structure can have significant biological consequences. This specific variant is categorized as a health predisposition marker, meaning its presence is linked to a higher likelihood of developing certain clinical conditions. It is important to note that genetic variants do not act in isolation; they interact with other genetic factors and environmental influences to shape an individual's health profile. Understanding this variant requires looking at how it disrupts the normal function of the PTEN protein, which acts as a tumor suppressor in the human body.
The Role of the PTEN Gene
The PTEN gene provides instructions for making an enzyme called phosphatase and tensin homolog. This enzyme functions as a tumor suppressor, which means it helps regulate the cell cycle by preventing cells from growing or dividing too rapidly or in an uncontrolled way. By acting as a 'brake' on cell division, PTEN plays a vital role in maintaining the stability of the body's tissues. When the PTEN gene is altered, the resulting protein may be non-functional or absent, leading to a loss of this critical regulatory control. This loss of function is the hallmark of PTEN hamartoma tumor syndrome (PHTS). Without a working PTEN protein, cells may accumulate mutations and grow into hamartomas—benign, tumor-like growths—or progress into malignant cancers over time.
Research and Clinical Associations
Research links germline variants in the PTEN gene, including rs121913059, to a spectrum of conditions collectively known as PTEN hamartoma tumor syndrome (PHTS). This syndrome encompasses several clinical phenotypes, such as Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome. Individuals with these variants face an increased lifetime risk for developing cancers in the breast, thyroid, kidney, and endometrium, among others. The evidence for these associations is grounded in clinical observations of families and individuals who carry pathogenic PTEN variants. While the link between PTEN dysfunction and cancer risk is well-established, the specific clinical expression can vary significantly between individuals, even those with the same variant. This variability is a subject of ongoing research, as scientists work to understand why some carriers develop specific tumors while others do not.
Population Frequency
The rs121913059 variant is extremely rare in the general population. According to data from the Genome Aggregation Database (gnomAD), the global minor allele frequency is less than 0.00001. This low frequency indicates that the variant is not a common polymorphism but rather a rare genetic event. Because it is so uncommon, it is rarely encountered in the general public, and its presence is typically identified in clinical settings where individuals are being evaluated for specific hereditary cancer syndromes. The rarity of this variant underscores the importance of specialized genetic counseling for those who receive a positive result, as it is not a common variation found in the average person's genetic makeup.
Navigating Genetic Information
If you or a family member have been identified as a carrier of a PTEN variant, it is essential to consult with a certified genetic counselor or a medical geneticist. This information is not a diagnosis, but rather a tool to help clinicians develop personalized health surveillance strategies. Because PHTS is associated with specific cancer risks, medical professionals often recommend regular screenings for breast, thyroid, and other cancers to ensure early detection. You cannot change your genetic sequence, but you can use this information to make informed decisions about your healthcare. Always discuss your genetic results with a qualified healthcare provider who can interpret the findings in the context of your personal and family medical history. Avoid making medical decisions based solely on raw genetic data without professional clinical guidance.
How common is this variant?
The rs121913059 variant is extremely rare, with a global minor allele frequency of less than 0.00001 in the gnomAD database.
Frequently asked questions
What is PTEN hamartoma tumor syndrome?
PTEN hamartoma tumor syndrome (PHTS) is a group of rare genetic disorders caused by mutations in the PTEN gene. It is characterized by the growth of hamartomas and an increased risk of developing certain types of cancer.
Does having this variant mean I will get cancer?
No, having a variant does not guarantee that you will develop cancer. It indicates a higher predisposition, meaning your risk is statistically higher than the general population, which helps guide medical surveillance.
How is this variant diagnosed?
This variant is typically identified through molecular genetic testing, such as sequencing of the PTEN gene. This is usually performed in a clinical setting after a healthcare provider suspects a hereditary syndrome.
What should I do if I have this variant?
You should consult with a genetic counselor or a specialist who can explain the implications for your health. They will likely recommend a personalized cancer screening plan based on your specific genetic profile.
Sources & further reading
Educational information only, last refreshed 9/26/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121913059?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29